Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients
Julia Lappin, Marlene Wijaya, Andrew Watkins, et al.
Schizophrenia Research (2018) Vol. 199, pp. 367-373
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression
Sixin Li, Dong Yang, Chao Zhou, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 25
A Focused Review of the Metabolic Side-Effects of Clozapine
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Pharmacological interventions for prevention of weight gain in people with schizophrenia
Sri Mahavir Agarwal, Nicolette Stogios, Zohra Ahsan, et al.
Cochrane library (2022) Vol. 2023, Iss. 1
Open Access | Times Cited: 34
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 17
The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review
Rasha Alkholy, Karina Lovell, Penny Bee, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0308037-e0308037
Open Access
Effectiveness of Clozapine compared to Non-Clozapine Antipsychotics in Older Adults with Schizophrenia in Brazil in a 16-year follow-up
Júlio César Menezes Vieira, Edna Afonso Reis, Wallace Mateus Prata, et al.
American Journal of Geriatric Psychiatry (2025)
Closed Access
The dosage-dependent effects of cevimeline in preventing clozapine-induced dyslipidaemia in female rats
Jiamei Lian, Bo Pan, Chao Deng
Pharmacology Biochemistry and Behavior (2025), pp. 174017-174017
Open Access
Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis
Hiba Mutwalli, Johanna Louise Keeler, Sevgi Bektas, et al.
Journal of Psychiatric Research (2023) Vol. 160, pp. 137-162
Open Access | Times Cited: 10
Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication
Rachel Morell, Jackie Curtis, Andrew Watkins, et al.
Psychiatry Research (2019) Vol. 281, pp. 112606-112606
Closed Access | Times Cited: 21
Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia
Yue Feng Quek, Yuen Mei See, Jie Yin Yee, et al.
Asian Journal of Psychiatry (2022) Vol. 74, pp. 103192-103192
Closed Access | Times Cited: 10
Routine screening and rates of metabolic syndrome in patients treated with clozapine and long-acting injectable antipsychotic medications: a cross-sectional study
Anne Lydon, John F. Vallely, A. Tummon, et al.
Irish Journal of Psychological Medicine (2020) Vol. 38, Iss. 1, pp. 40-48
Closed Access | Times Cited: 15
Organization of Community Mental Health Services for Persons with a Severe Mental Illness and Comorbid Somatic Conditions: A Systematic Review on Somatic Outcomes and Health Related Quality of Life
Nicolaas Martens, Marianne Destoop, Geert Dom
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 2, pp. 462-462
Open Access | Times Cited: 14
Frailty and Treatment-Resistant Schizophrenia: A Retrospective Cohort Study
Ella Pearson, Dan Siskind, Ruth E. Hubbard, et al.
Community Mental Health Journal (2022) Vol. 59, Iss. 1, pp. 105-109
Closed Access | Times Cited: 9
Common mechanisms for type 2 diabetes and psychosis: Findings from a prospective birth cohort
Benjamin I. Perry, Hannah Jones, Tom G. Richardson, et al.
Schizophrenia Research (2020) Vol. 223, pp. 227-235
Open Access | Times Cited: 14
Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia
Chuanjun Zhuo, Yong Xu, Haibo Wang, et al.
Journal of Affective Disorders (2021) Vol. 295, pp. 163-172
Open Access | Times Cited: 12
Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort
Juan Andrés Martínez-Andrés, Juan Antonio García-Carmona
International Clinical Psychopharmacology (2019) Vol. 35, Iss. 3, pp. 163-169
Closed Access | Times Cited: 12
Commando care for individuals living with severe mental illness: Equally Well goes beyond metabolic health alone
Patrick Bolton, Kimberley Davies, Sarah Grattan, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 7, pp. 545-548
Closed Access | Times Cited: 1
Prevalence and correlates of food insecurity in community-based individuals with severe mental illness receiving long-acting injectable antipsychotic treatment
Scott Teasdale, Rachel Morell, Julia Lappin, et al.
British Journal Of Nutrition (2020) Vol. 124, Iss. 4, pp. 470-477
Closed Access | Times Cited: 11
Underuse of recommended treatments among people living with treatment-resistant psychosis
Julia Lappin, Kimberley Davies, Maryanne O’Donnell, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 7
The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services
Thomas R. E. Barnes, James H. MacCabe, John M. Kane, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10, pp. 204512532093790-204512532093790
Open Access | Times Cited: 9
Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
Tommaso Sciarra, Mario Ciccotti, Paola Aiello, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 9
The tertiary service for psychosis: Holistic recommendations for people with complex psychosis
Kimberley Davies, Sarah Grattan, Chloe Gott, et al.
Australasian Psychiatry (2023) Vol. 31, Iss. 5, pp. 591-597
Open Access | Times Cited: 3
Pharmacogenetic Factors of Clozapine-Induced Metabolic Syndrome
Aiperi K. Khasanova
Personalized Psychiatry and Neurology (2023) Vol. 3, Iss. 2, pp. 38-47
Open Access | Times Cited: 3
Physical health trajectories of young people commenced on clozapine
Brian O’Donoghue, Ajdin Mujanovic, Su Ling Young, et al.
Irish Journal of Psychological Medicine (2020) Vol. 38, Iss. 1, pp. 49-55
Closed Access | Times Cited: 6
Fatal poisonings involving clozapine: A 16-year review of Australian coronial investigations
Jessica L. Dawson, Janet K. Sluggett, Jennifer Schumann, et al.
Australian & New Zealand Journal of Psychiatry (2021) Vol. 56, Iss. 1, pp. 50-58
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top